25 filings
8-K
RARX
Ra Pharmaceuticals, Inc.
2 Apr 20
UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients
4:02pm
8-K
RARX
Ra Pharmaceuticals, Inc.
31 Mar 20
Other Events
6:01am
8-K
RARX
Ra Pharmaceuticals, Inc.
16 Mar 20
Entry into a Material Definitive Agreement
12:00am
8-K
RARX
Ra Pharmaceuticals, Inc.
28 Feb 20
Other Events
12:00am
8-K
RARX
Ra Pharmaceuticals, Inc.
18 Dec 19
Submission of Matters to a Vote of Security Holders
6:04am
8-K
mz11ermrzcvaqx ywpmf
25 Nov 19
Other Events
6:04am
8-K
5mgivhr9nngui
10 Oct 19
Entry into a Material Definitive Agreement
9:05am
8-K
fet6aom0m34aqi41aih
26 Jul 19
Other Events
10:53am
8-K
fmgl65p0 oe
16 Jul 19
Entry into a Material Definitive Agreement
7:15am
8-K
0ee n9tonc3qu
12 Jun 19
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
tsr2zaivmft uzcrgg
9 May 19
Entry into a Material Definitive Agreement
4:42pm
8-K
q66s m34o
14 Dec 18
Other Events
6:03am
8-K
g4d2369n2d9 i1n88
11 Dec 18
Termination of a Material Definitive Agreement
5:24pm
8-K
zecqd4
10 Dec 18
Other Events
4:15pm
8-K
mmx2wsuj2
15 Nov 18
Departure of Directors or Certain Officers
4:30pm
8-K
r5h4jmzfl
25 Sep 18
Departure of Directors or Certain Officers
9:16am
8-K
uzf6vo44iqh9
29 Jun 18
Submission of Matters to a Vote of Security Holders
8:13am
8-K
8xb t2qn3tyb6
7 Jun 18
Regulation FD Disclosure
8:19am
8-K
w3hqc e38id
9 May 18
Entry into a Material Definitive Agreement
5:25pm
8-K
i6dsg9wmi9r
16 Feb 18
Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am